ACRYLIC ACID PRODUCTION METHODS
    3.
    发明申请
    ACRYLIC ACID PRODUCTION METHODS 审中-公开
    丙烯酸生产方法

    公开(公告)号:US20160016876A1

    公开(公告)日:2016-01-21

    申请号:US14378456

    申请日:2013-02-20

    申请人: Novomer, Inc.

    发明人: James E. Mahoney

    摘要: In one aspect, the present invention encompasses safe and efficient methods for providing highly pure acrylic acid. In certain embodiments, the inventive methods include the step of producing polypropiolactone from ethylene oxide at a first location, transporting the polymer to a second location and pyrolyzing the polypropiolactone to provide glacial acrylic acid. In certain embodiments, the step of pyrolyzing the polymer is performed continuously in conjunction with a polymerization process to make SAPs.

    摘要翻译: 一方面,本发明包括用于提供高纯度丙烯酸的安全和有效的方法。 在某些实施方案中,本发明的方法包括在第一位置从环氧乙烷生产聚丙内酯的步骤,将聚合物输送到第二位置并热解聚丙内酯以提供冰丙烯酸。 在某些实施方案中,热解聚合物的步骤连续地与聚合方法一起进行以制备SAP。

    Hypoestoxides, derivatives and agonists thereof for use as antiviral
agents
    9.
    发明授权
    Hypoestoxides, derivatives and agonists thereof for use as antiviral agents 失效
    用作抗病毒药物的次高毒素,其衍生物和激动剂

    公开(公告)号:US6001871A

    公开(公告)日:1999-12-14

    申请号:US7308

    申请日:1998-01-15

    摘要: A method for inhibiting the growth of lentiviruses and Herpetoviridae viruses, including HIV-1 and HSV-1, -2, respectively, in subjects, comprising administering to a subject in need of antiviral therapy a pharmaceutical composition comprising a therapeutically effective amount of a compound of the formula ##STR1## where: R is(i) H, PO.sub.3.sup..dbd., alkyl of 1 to 12 carbon atoms substituted or unsubstituted, straight chain or branched, 0 to 6 double bonds, (CH.sub.2).sub.n morpholine where n=1-4, morpholinomethylphenyl, orthoaminophenyl, orthohydroxyphenyl, (CH.sub.2).sub.n COOR.sub.2 where n=1-4where R.sub.2 is H, an alkalai metal salt, an alkaline earth metal salt, NH.sub.4.sup..dbd., N.sup.+ (R.sub.3).sub.4where R.sub.3 is independently selected from the group consisting of H and alkyl of 1 to 4 carbon atoms, or(ii) COR.sub.1 wherein R.sub.1 is selected from the group consisting of H, (CH.sub.2).sub.n CH.sub.3, where n=0-6, (CH.sub.2).sub.n COOR.sub.2 where n=1-4 and R.sub.2 is previously defined, (CH.sub.2).sub.n N.sup.+ (R.sub.3).sub.4 wherein n=1-4, and (CH.sub.2).sub.n S0.sub.3.sup.- where n=1-4,and pharmaceutically acceptable salts thereof.

    摘要翻译: 分别在受试者中抑制慢病毒和疱疹病毒科病毒(包括HIV-1和HSV-1,-2)的生长的方法,包括向需要抗病毒治疗的受试者施用包含治疗有效量的化合物 其中:R是(i)H,PO3 =,取代或未取代的直链或支链的0至6个双键,(CH 2)nm吗啉取代或未取代的烷基,其中n = 1-4,吗啉代甲基苯基, 邻氨基苯基,邻羟基苯基,(CH2)nCOOR2其中n = 1-4,其中R2是H,碱金属盐,碱土金属盐,NH4 =,N +(R3)4,其中R3独立地选自H和 具有1至4个碳原子的烷基,或(ii)COR1,其中R1选自H,(CH2)nCH3,其中n = 0-6,(CH2)nCOOR2,其中n = 1-4,R2为 其中n = 1-4的(CH 2)n N +(R 3)4和其中n = 1-4的(CH 2)n SO 3 - 及其药学上可接受的盐。